Skip to content

Stock Symbol: RCAR

RenovaCare
Cell Renewal, Naturally.
RenovaCareRenovaCare
  • Corporate
    • About Us
    • Our Team
  • Science
    • Our Technology
    • Publications
  • Gallery
    • Our Photos
    • Our Videos
  • News
    • Press Releases
    • Media Coverage
    • Press Kit / Media
  • Investors
    • Overview
    • Email Alerts
    • SEC Filings
    • Investor FAQs
    • Corporate Governance
  • Contact
    • Contact Us
Search:
  • Corporate
    • About Us
    • Our Team
  • Science
    • Our Technology
    • Publications
  • Gallery
    • Our Photos
    • Our Videos
  • News
    • Press Releases
    • Media Coverage
    • Press Kit / Media
  • Investors
    • Overview
    • Email Alerts
    • SEC Filings
    • Investor FAQs
    • Corporate Governance
  • Contact
    • Contact Us

Daily Archives: March 24, 2022

RenovaCare Announces Management Changes

News & Events, Press ReleasesBy amit.damaakMarch 24, 2022

Scottsdale, AZ – March 24, 2022 – RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), clinical-stage developer of patented cell therapy technologies for the regeneration of skin and tissues, today announced reductions in its management team to further streamline administrative expenses.

© Copyright RenovaCare, Inc. Third party logos do not represent affiliation or endorsement.
RenovaCare products are under development and not approved for sale in the United States.
Results may vary from person to person.

Disclaimer & Privacy Policy | Contact |

Go to Top